about
Clinical trials and medical care: defining the therapeutic misconceptionWhole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.The OHRP and SUPPORTChemotherapy drug shortages in pediatric oncology: a consensus statementBiomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act CoverageRecommendations for the return of research results to study participants and guardians: a report from the Children's Oncology GroupSharing of clinical trial data among trialists: a cross sectional surveyInformed consent for medical treatment and research: a review.The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsAssigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Inflammatory bowel disease associated with immune thrombocytopenic purpura in children.Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.A taxonomy of medical uncertainties in clinical genome sequencingExperiences and attitudes of genome investigators regarding return of individual genetic test results.Quality of informed consent in cancer clinical trials: a cross-sectional survey.Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician surveyA unique researcher identifier for the Physician Payments Sunshine Act.Addressing the ethical challenges in genetic testing and sequencing of children.Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.Research ethics. Paying patients for their tissue: the legacy of Henrietta LacksPrivate cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians.What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics.Discontinuing bevacizumab in patients with glioblastoma: an ethical analysisComparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review."Entering a Clinical Trial: Is it Right for You?": a randomized study of The Clinical Trials Video and its impact on the informed consent processOutcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.Variation in supportive care practices in hematopoietic cell transplantation.Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.A randomized study of how physicians interpret research funding disclosures.Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastomaConsiderations about hastening death among parents of children who die of cancer.Involving children with cancer in decision-making about research participation.Advance care planning in patients undergoing hematopoietic cell transplantation.When Participants in Genomic Research Grow Up: Contact and Consent at the Age of MajorityClinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.Incidental findings in human subjects research: what do investigators owe research participants?Parents' views of cancer-directed therapy for children with no realistic chance for curePoint-counterpoint. Ethics and genomic incidental findings
P50
Q21144663-4D000F8A-FB37-4550-91C8-70FABFE64351Q27853005-042C6A6C-1D44-40BF-BC74-EB20FF4E2690Q28292121-FB2D5986-713B-4075-BFA8-1F6EA2DE9674Q28307153-139AC5CF-E8F8-40A9-9394-52D0305D8305Q28468454-E82ACD06-9652-418D-9CFC-A20F56DC59D9Q28710366-5A628235-B68F-440A-AA77-97F4BBCA1DFAQ28710576-FA939F85-6320-4271-B15B-8CFBABD70179Q30351427-99C0BA46-A447-4617-8264-53B39D456BABQ30557206-753BADA7-97A9-4520-9D45-3676B5C44CB5Q31157014-FA603D4B-172E-407F-B233-AA0EBAD33EFEQ33340146-33233B1D-892B-4D55-B363-E3F008F3C632Q33605181-98B2348C-14F0-46EC-AB58-9ACECFAF1A1BQ33918222-215C5794-FAC3-4CEA-BC84-F2FDB7697459Q34084171-6AF7D424-5547-4170-9069-F8B40FDD1FA0Q34104151-0BB97D98-A3B8-46FD-A0C9-22BD9967D6D9Q34177859-F759385D-00DB-4D95-9E4C-E500B81BB5DBQ34185638-CBC69B51-0EB9-41AB-8CF7-F2D185721C46Q34408150-DFB5771F-9D80-405E-9017-4C81F3490B75Q34578579-9621EEEC-D661-49D0-B2C2-B4086460CFD1Q34633036-864EC152-31E4-43C7-8CA9-6012C31B8706Q34955390-929CBF53-8A2E-4688-BD63-BBBC52206E3BQ35425237-C5F29DA0-BBBB-47C0-A155-11245B9686A7Q35584395-2AA42C55-A603-4A63-8C9C-5EA879C7A2E6Q35642930-291D61D3-C75A-4CE8-BF29-0AA4217E3CE9Q35685473-966D422D-3CB8-4313-A245-9C572B1D288FQ35782852-11A90AD2-C2A5-4D92-AF20-A6F67D668345Q35832808-0D2CD2B9-301D-4F55-9DDF-A01F6D362037Q36055266-E78B3F06-3012-495D-88DD-50BE25CBB222Q36513939-30F5FFDF-585E-40D5-9E93-6D7487119BF4Q36589638-5506A082-437C-468B-8726-FBE166C69A3FQ36597539-8925E7A4-B977-443D-9D3E-6F34CDF1471EQ36669850-E3FEAD3F-6DEA-49C5-BB85-6D1967C848E8Q36707837-A57D8CB8-67AE-4229-85E9-1C6F3B66611CQ36775822-F79DB579-1ACE-435F-8118-C4378D138ECBQ36896390-A8DA3C69-774D-4C59-A9B6-9302724312FAQ36951734-0F9EA38A-5AC1-4D85-B7E3-8B17671B66E8Q36960349-099F1D80-A213-4375-AA9F-C7AF21120282Q37029722-64363A37-0AD0-423B-B82B-2EA847CBC3DDQ37121704-573E67DE-33A6-4587-AED3-2783C4CF5B6DQ37169821-E8CD3C6F-BA3F-48D6-AA50-0D7F2BFB726E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Steven Joffe
@ast
Steven Joffe
@en
Steven Joffe
@es
Steven Joffe
@nl
Steven Joffe
@sl
type
label
Steven Joffe
@ast
Steven Joffe
@en
Steven Joffe
@es
Steven Joffe
@nl
Steven Joffe
@sl
prefLabel
Steven Joffe
@ast
Steven Joffe
@en
Steven Joffe
@es
Steven Joffe
@nl
Steven Joffe
@sl
P106
P1153
35774031500
56733177200
P2038
Steven_Joffe
P21
P31
P3835
steven-joffe
P496
0000-0002-0667-7384